BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$83.26−1.60 (-1.89%)
Close on Nov 18, 2026Market cap $20.92BP/E –Yield –
BioNTech net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -€1.14B. The highest annual figure on record is €10.29B in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€1.14B | – |
| FY2024 | Dec 31, 2024 | -€665.30M | -171.5% |
| FY2023 | Dec 31, 2023 | €930.30M | -90.1% |
| FY2022 | Dec 31, 2022 | €9.43B | -8.3% |
| FY2021 | Dec 31, 2021 | €10.29B | +67613.8% |
| FY2020 | Dec 31, 2020 | €15.20M | – |
| FY2019 | Dec 31, 2019 | -€179.10M | – |
| FY2018 | Dec 31, 2018 | -€48.02M | – |
| FY2017 | Dec 31, 2017 | -€85.65M | – |
See a number that looks wrong?